Topics
Health
Pharma
Biotech
Politics & Policy
Health Tech
In the Lab
Business
Artificial Intelligence
Video
Coronavirus
Opinion
First Opinion
The Pharmalot View
Adam’s Take
Podcast
Newsletters
Reports
Events
Upcoming Events
STAT Health Tech Summit
Webinars
STAT Expert Advantage
Log in
Subscribe
Newsletters
Try STAT Plus
Newsletters
Try STAT Plus
Something Ventured
Something Ventured
Dyne Therapeutics and three other startups got venture funding a year ago. Will it be enough to get them through Covid-19?
By
Kate Sheridan
Something Ventured
Something Ventured: Vor Biopharma and 3 other startups got venture funding a year ago. Did it help them do what they said it would?
By
Kate Sheridan
Something Ventured
Compass Therapeutics and these three other biotech startups got venture funding a year ago. Where are they now?
By
Kate Sheridan
Something Ventured
Casma Therapeutics and four other startups got venture funding a year ago. Did it help them do what they said it would?
By
Kate Sheridan
Something Ventured
Finch Therapeutics and three other startups got venture funding a year ago. Did it help them do what they said it would?
By
Kate Sheridan
Something Ventured
These six biotech startups got venture funding a year ago. Where are they now?
By
Kate Sheridan
A roundup of STAT’s top stories of the day in science and medicine
Industry
Academia
Advertising/Marketing
Advocacy
Biotech
Consultancy/Firm
Financial Services
Government
Healthcare Payer
Healthcare Provider
Media
Medical Device
Non-profit
Pharma
Technology
Privacy Policy
Leave this field empty if you're human:
